Stock listing

Ocular Therapeutix, Inc.

Selected listing: OCUL · NASDAQ · USD · US

Ocular Therapeutix, Inc. (NASDAQ:OCUL), Health Technology. Latest release Oct 9, 2026: Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule…

OCUL:NASDAQUSDUSUpdated October 9, 2026

Ticker: NASDAQ:OCUL
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a public company traded under the ticker OCUL in the American market. Ocular Therapeutix focuses on developing and commercializing innovative therapies for eye diseases and conditions.

Latest news from Ocular Therapeutix, Inc.

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 8, 2026

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

October 1, 2026

Oculis Announces Resignation of Lionel Carnot from Board of Directors

September 30, 2026

Ocular Therapeutix™ Announces Positive Pre-NDA Meeting with U.S. FDA for AXPAXLI™ in Wet AMD

September 15, 2026

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

September 1, 2026

All Ocular Therapeutix, Inc. news →

Events

Replays

Ocular Therapeutix, Inc. (OCUL) Q1 2026 Earnings Call
Tue, May 05, 2026 · 08:00 AM ET
Watch
Ocular Therapeutix, Inc. (OCUL) Q3 2025 Earnings Call
Tue, Nov 04, 2025 · 08:00 AM ET
Watch
Ocular Therapeutix, Inc. (OCUL) Q2 2025 Earnings Call
Tue, Aug 05, 2025 · 08:00 AM ET
Watch

Research Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. company profile

View the public company page for Ocular Therapeutix, Inc. on 6ix.

Ocular Therapeutix, Inc. news

Read company news and market updates connected to Ocular Therapeutix, Inc..

Ocular Therapeutix, Inc. investor events

Find investor webinars, events, and replay context for Ocular Therapeutix, Inc..